最高10亿美元!和美国一家生物科技公司签了个“独家授权协议”!

企业上市
Oct 17, 2025

核心事件:南京维立志博生物科技公司(简称“维立志博”,股票代码9887)在2025年10月16日,和美国一家叫Dianthus的生物科技公司签了个“独家授权协议”。协议内容:授权什么:维立志博把自己研发的一款新药LBL-047(还处于临床前阶段)在大中华区(中国大陆、香港、澳门、台湾)以外的全球权益,独家授权给了Dianthus。Dianthus要做什么:负责这款药在海外市场的后续研发、生产和销售...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10